Metraipolis › archive › dc_757e05d6905f

Phase III Trial: Single Low-Dose 5 mg Dexamethasone with NEPA for Preventing 168 h Nausea and Vomiting of Diverse Highly or Moderately Emetogenic Chemotherapy… — Europe PMC PMID:42505559

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42505559
DOI
10.3390/diseases14070231
License (as archived)
solo-consultazione
Archived
2026-10-26T19:59:58.371Z
SHA-256 of the archived text
271532cd866ca8cd052af503833f5eba5acf52a52f6fdc3c5223b184ef0e39fa
Stable URL of this page
https://metraipolis.com/documento/dc_757e05d6905f

How to cite

Phase III Trial: Single Low-Dose 5 mg Dexamethasone with NEPA for Preventing 168 h Nausea and Vomiting of Diverse Highly or Moderately Emetogenic Chemotherapy… — Europe PMC PMID:42505559 — Europe PMC (en), https://europepmc.org/article/MED/42505559 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_757e05d6905f (Metraipolis archive dc_757e05d6905f, sha256 271532cd866ca8cd052af503833f5eba5acf52a52f6fdc3c5223b184ef0e39fa)
BibTeX
@misc{dc757e05d6905f,
  title = {Phase III Trial: Single Low-Dose 5 mg Dexamethasone with NEPA for Preventing 168 h Nausea and Vomiting of Diverse Highly or Moderately Emetogenic Chemotherapy… — Europe PMC PMID:42505559},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42505559},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_757e05d6905f; sha256 271532cd866ca8cd052af503833f5eba5acf52a52f6fdc3c5223b184ef0e39fa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42505559. Agents can read the archived copy with the MCP tool read_document.